Elexacaftor/tezacaftor/ivacaftor improves nasal nitric oxide in patients with cystic fibrosis.
Pioch CO, Ziegahn N, Allomba C, Busack LM, Schnorr AN, Tosolini A, Fuhlrott BR, Zagkla S, Othmer T, Syunyaeva Z, Graeber SY, Yoosefi M, Thee S, Steinke E, Röhmel J, Mall MA, Stahl M.
Pioch CO, et al. Among authors: syunyaeva z.
J Cyst Fibros. 2024 Sep;23(5):863-869. doi: 10.1016/j.jcf.2024.03.003. Epub 2024 Mar 19.
J Cyst Fibros. 2024.
PMID: 38508948
Free article.